Document ID: FDA-2001-N-0202-0002
Agency: fda
Document Type: Notice
Title: Workshop on Preclinical Testing for Endovascular Grafts
Posted Date: 2001-10-10T04:00Z

[Federal Register: July 2, 2001 (Volume 66, Number 127)]
[Notices]               
[Page 34945]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02jy01-87]                         

[[Page 34945]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Workshop on Preclinical Testing for Endovascular Grafts

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    This notice announces the forthcoming workshop on preclinical 
testing for endovascular grafts, sponsored by the Food and Drug 
Administration (FDA). The meeting will be open to the public.
    Date and Time: The meeting will be held on July 31, 2001, 9 a.m. to 
6 p.m., and August 1, 2001, 9 a.m. to 5 p.m.
    Location: Gaithersburg Holiday Inn, Walker-Whetstone Room, Two 
Montgomery Village Ave., Gaithersburg, MD.
    Contact: The workshop organizers are Megan Moynahan, 301-443-8517, 
ext. 171, mbm@cdrh.fda.gov, and Dorothy Abel, 301-443-8262, ext. 165, 
dba@cdrh.fda.gov, Center for Devices and Radiological Health (HFZ-450), 
Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 
20850.
    Agenda: The workshop will concern endovascular grafts used in the 
treatment of abdominal aortic aneurysms. The goal of the workshop is to 
find ways to improve how these grafts are tested. Participants of the 
workshop will first be asked to describe the environment to which these 
grafts are exposed. Then they will identify the failure modes of the 
grafts and examine how the devices have been tested to date. Finally, 
the participants will be asked to suggest ways to modify the testing of 
these devices by taking into consideration the graft environment.
    Workshop participation is by invitation only and is therefore 
limited. However, the public may observe as audience members. 
Background information for the workshop will be available to the public 
on the Internet at http://www.fda.gov/cdrh/meetings/
073101workshop.html.
    Procedure: Members of the public who are interested in attending as 
audience members should contact the workshop organizers by July 13, 
2001.
    If you need special accommodations due to a disability, please 
contact either one of the contact persons listed above at least 7 days 
in advance.

    Dated: June 25, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-16471 Filed 6-29-01; 8:45 am]
BILLING CODE 4160-01-S